Spontaneous remission of acute myeloid leukemia

References

• Hoption Cann SA, van Netten JP, van Netten C. Dr William Coley and tumour regression:a place in history or in the future. Postgrad Med J 2003;79:672–680.
   PubMed Web of Science ®Google Scholar
• Cole WH, Everson TC. Spontaneous regression of cancer: preliminary report. Ann Surg 1956;144:366–383.
   PubMed Web of Science ®Google Scholar
• Eisenlohr C. Leucaemia lienalis, lymphatica et medullaris mit multiplen Gehirnnervenlähmungen. Virchows Arch 1878;73:56–73.
   Google Scholar
• Richter PF. Lukamie and erysipel. Charité Annal 1896;21:299–309.
   Google Scholar
• Williams BA, Meyn MS, Hitzler JK. Transient leukemia in newborns without down syndrome:diagnostic and management challenges. J Pediatr Hematol Oncol 2011;33:e261–e263.
   Google Scholar
• Massey GV. Transient leukemia in newborns with Down syndrome. Pediatr Blood Cancer 2005;44:29–32.
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009; 114:937–951.
   PubMed Web of Science ®Google Scholar
• Slovak ML, Kopecky KJ, Cassileth PA, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000;96:4075–4083.
   PubMed Web of Science ®Google Scholar
• Southam CM, Craver LF, Dargeon HW, et al. A study of the natural history of acute leukemia with special reference to the duration of the disease and the occurrence of remissions. Cancer 1951;4:39–59.
   PubMed Web of Science ®Google Scholar
• Pelner L, Fowler GA, Nauts HC. Effects of concurrent infections and their toxins on the course of leukemia. Acta Med Scand Suppl 1958;338:1–47.
   PubMedGoogle Scholar
• Tivey H. The natural history of untreated acute leukemia. Ann NY Acad Sci 1954;60:322–358.
   PubMedGoogle Scholar
• Kolmel KF, Pfahlberg A, Mastrangelo G, et al. Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of Cancer. Melanoma Res 1999;9:511–519.
   PubMed Web of Science ®Google Scholar
• Chen L. Immunological ignorance of silent antigens as an explanation of tumor evasion. Immunol Today 1998;19:27–30.
   PubMedGoogle Scholar
• Basu S, Srivastava PK. Fever-like temperature induces maturation of dendritic cells through induction of hsp90. Int Immunol 2003;15:1053–1061.
   PubMed Web of Science ®Google Scholar
• Multhoff G. Activation of natural killer cells by heat shock protein 70. Int J Hyperthermia 2002;18:576–585.
   PubMed Web of Science ®Google Scholar
• Gross C, Schmidt-Wolf IG, Nagaraj S, et al. Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells. Cell Stress Chaperones 2003;8:348–360.
   PubMed Web of Science ®Google Scholar
• Radons J, Multhoff G. Immunostimulatory functions of membrane-bound and exported heat shock protein 70. Exerc Immunol Rev 2005;11:17–33.
   PubMed Web of Science ®Google Scholar
• Nauts H, Pelner L, Foweler G. Sarcoma of the soft tissues, other than lymphosarcoma, treated by toxin therapy. End results in 186 determinant cases with microscopic confirmation of the diagnosis: 49 operable, 137 inoperable. NY Cancer Res Inst Monogr 1969:3.
   Google Scholar
• Dickson JA. Hyperthermia in the treatment of cancer. Lancet 1979;1:202–205.
   PubMed Web of Science ®Google Scholar
• Heijkoop ST, van Doorn HC, Stalpers LJ, et al. Results of concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after previous chemoradiation. Int J Hyperthermia 2014;30: 6–10.
   PubMed Web of Science ®Google Scholar
• Pardoll D. T cells take aim at cancer. Proc Natl Acad Sci USA 2002;99:15840–15842.
   PubMed Web of Science ®Google Scholar
• Romero P, Dunbar PR, Valmori D, et al. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J Exp Med 1998;188:1641–1650.
   PubMed Web of Science ®Google Scholar
• Vazquez-Cintron EJ, Monu NR, Frey AB. Tumor-induced disruption of proximal TCR-mediated signal transduction in tumor-infiltrating CD8 + lymphocytes inactivates antitumor effector phase. J Immunol 2010;185:7133–7140.
   PubMed Web of Science ®Google Scholar
• Olurinde MO, Shen CH, Drake A, et al. Persistence of tumor-infiltrating CD8 T cells is tumor-dependent but antigen-independent. Cell Mol Immunol 2011;8:415–423.
   Google Scholar
• Teague RM, Kline J. Immune evasion in acute myeloid leukemia: current concepts and future directions. J Immunother Cancer 2013;1: pii: 1/1/13.
   Google Scholar
• Buggins AG, Milojkovic D, Arno MJ, et al. Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways. J Immunol 2001;167:6021–6030.
   PubMed Web of Science ®Google Scholar
• Marcucci G. Arginase-mediated “field” defects in AML. Blood 2013;122:620–621.
   PubMed Web of Science ®Google Scholar
• Mussai F, De Santo C, Abu-Dayyeh I, et al. Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment. Blood 2013;122:749–758.
   PubMed Web of Science ®Google Scholar
• Mitterbauer M, Fritzer-Szekeres M, Mitterbauer G, et al. Spontaneous remission of acute myeloid leukemia after infection and blood transfusion associated with hypergammaglobulinaemia. Ann Hematol 1996;73:189–193.
   PubMed Web of Science ®Google Scholar
• Jimemez C, Ribera JM, Abad E, et al. Increased serum tumour necrosis factor during transient remission in acute leukaemia. Lancet 1993;341:1600.
   PubMed Web of Science ®Google Scholar
• Musto P, D’Arena G, Melillo L, et al. Spontaneous remission in acute myeloid leukaemia:a role for endogenous production of tumour necrosis factor and interleukin-2? Br J Haematol 1994;87:879–880.
   PubMed Web of Science ®Google Scholar
• Muller CI, Trepel M, Kunzmann R, et al. Hematologic and molecular spontaneous remission following sepsis in acute monoblastic leukemia with translocation (9;11): a case report and review of the literature. Eur J Haematol 2004;73:62–66.
   PubMed Web of Science ®Google Scholar
• Muller-Schmah C, Solari L, Weis R, et al. Immune response as a possible mechanism of long-lasting disease control in spontaneous remission of MLL/AF9-positive acute myeloid leukemia. Ann Hematol 2012;91:27–32.
   PubMed Web of Science ®Google Scholar
• Taylor AW. Effects of glandular fever infection in acute leukaemia. Br Med J 1953;1:589–593.
   PubMed Web of Science ®Google Scholar
• Gutterman JU, Hersh EM, Rodriguez V, et al. Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G. Lancet 1974;2:1405–1409.
   Google Scholar
• Whittaker JA, Bailey-Wood R, Hutchins S. Active immunotherapy for the treatment of acute myelogenous leukaemia:report of two controlled trials. Br J Haematol 1980;45:389–400.
   PubMed Web of Science ®Google Scholar
• Grimwade D, Hills RK, Moorman AV, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 2010;116:354–365.
   PubMed Web of Science ®Google Scholar
• Smits EL, Berneman ZN, Van Tendeloo VF. Immunotherapy of acute myeloid leukemia: current approaches. Oncologist 2009;14: 240–252.
   PubMed Web of Science ®Google Scholar
• Foa R. Interleukin 2 in the management of acute leukaemia. Br J Haematol 1996;92:1–8.
   PubMed Web of Science ®Google Scholar
• Maraninchi D, Vey N, Viens P, et al. A phase II study of interleukin-2 in 49 patients with relapsed or refractory acute leukemia. Leuk Lymphoma 1998;31:343–349.
   PubMed Web of Science ®Google Scholar
• Lee JJ, Kook H, Park MS, et al. Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation. J Clin Apher 2004;19:66–70.
   PubMed Web of Science ®Google Scholar
• Fujii S, Fujimoto K, Shimizu K et al. Presentation of tumor antigens by phagocytic dendritic cell clusters generated from human CD34 + hematopoietic progenitor cells: induction of autologous cytotoxic T lymphocytes against leukemic cells in acute myelogenous leukemia patients. Cancer Res 1999;59:2150–2158.
   PubMed Web of Science ®Google Scholar
• Schurch CM, Riether C, Ochsenbein AF. Dendritic cell-based immunotherapy for myeloid leukemias. Front Immunol 2013;4:496.
   Google Scholar
• Powles RL, Lister TA, Crowther D, et al. Immunotherapy for acute myelogenous leukemia. Bibl Haematol 1975;(40):737–749.
   PubMedGoogle Scholar
• Powles RL, Russell J, Lister TA, et al. Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 years after entry of the last patient. Br J Cancer 1977;35:265–272.
   PubMed Web of Science ®Google Scholar
• Zhang WG, Liu SH, Cao XM, et al. A phase-I clinical trial of active immunotherapy for acute leukemia using inactivated autologous leukemia cells mixed with IL-2, GM-CSF, and IL-6. Leuk Res 2005;29: 3–9.
   PubMed Web of Science ®Google Scholar
• Miller JS, Soignier Y, Panoskaltsis-Mortari A, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 2005;105:3051–3057.
   PubMed Web of Science ®Google Scholar
• Pizzitola I, Anjos-Afonso F, Rouault-Pierre K, et al. Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo. Leukemia 2014;28: 1596–1605.
   PubMed Web of Science ®Google Scholar
• Walter RB. Biting back: BiTE antibodies as a promising therapy for acute myeloid leukemia. Expert Rev Hematol 2014;7: 317–319.
   PubMed Web of Science ®Google Scholar
• Zeng Q, Yuan Y, Li P, et al. Spontaneous remission in patients with acute myeloid leukemia with t(8;21) or cutaneous myeloid sarcoma: two case reports and a review of the literature. Intern Med 2013;52:1227–1233.
   PubMed Web of Science ®Google Scholar
• Tzankov A, Ludescher C, Duba HC, et al. Spontaneous remission in a secondary acute myelogenous leukaemia following invasive pulmonary aspergillosis. Ann Hematol 2001;80:423–425.
   PubMed Web of Science ®Google Scholar
• Ifrah N, James JM, Viguie F, et al. Spontaneous remission in adult acute leukemia. Cancer 1985;56:1187–1190.
   PubMed Web of Science ®Google Scholar
• Jehn UW, Mempel MA. Spontaneous remission of acute myeloid leukemia. A report of a case and brief review of the literature. Blut 1986;52:165–168.
   Google Scholar
• Wiernik PH. Spontaneous regression of hematologic cancers. Natl Cancer Inst Monogr 1976;44:35–38.
   PubMedGoogle Scholar
• Enck RE. Spontaneous complete remission in acute promyelocytic leukemia. NY State J Med 1985;85:662.
   PubMedGoogle Scholar
• Aderka D, Shoenfeld Y, Berliner S, et al. Spontaneous remission of erythroleukemia following interstitial pneumonia. NY State J Med 1981;81:772–773.
   PubMedGoogle Scholar
• Xie W, Zhao Y, Cao L, et al. Cutaneous blastic plasmacytoid dendritic cell neoplasm occurring after spontaneous remission of acute myeloid leukemia: a case report and review of literature. Med Oncol 2012;29:2417–2422.
   PubMed Web of Science ®Google Scholar
• Tsavaris N, Kopterides P, Kosmas C, et al. Spontaneous remission of acute myeloid leukemia associated with GnRH agonist treatment. Leuk Lymphoma 2006;47:557–560.
   PubMed Web of Science ®Google Scholar
• Trof RJ, Beishuizen A, Wondergem MJ, et al. Spontaneous remission of acute myeloid leukaemia after recovery from sepsis. Neth J Med 2007;65:259–262.
   PubMed Web of Science ®Google Scholar
• Teng CJ, Yang CF, Gau JP, et al. Spontaneous remission in acute myelogenous leukemia evidenced by cytogenetic changes. Ann Hematol 2011;90:981–983.
   PubMed Web of Science ®Google Scholar
• Spadea A, Latagliata R, Martinelli E, et al. Transient spontaneous remission in a case of adult acute myelogenous leukaemia. Br J Haematol 1990;76:154.
   PubMed Web of Science ®Google Scholar
• Shimohakamada Y, Shinohara K, Fukuda N. Remission of acute myeloblastic leukemia after severe pneumonia treated with high-dose methylprednisolone. Int J Hematol 2001;74:173–177.
   PubMed Web of Science ®Google Scholar
• Ruutu T, Teerenhovi L, Vuorinen E, et al. Spontaneous remission in acute myeloid leukaemia. Acta Haematol 1982;67:211–213.
   PubMed Web of Science ®Google Scholar
• Kang HJ, Yoon JH, Cho HI, et al. Transient spontaneous remission in acute promyelocytic leukemia—two case reports. J Korean Med Sci 1993;8:166–170.
   PubMedGoogle Scholar
• Lachant NA, Goldberg J, Nelson DA, et al. Spontaneous remission in acute myelogenous leukemia in the adult. Am J Med 1979;67: 687–692.
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Al-Khatti AA. Spontaneous remission of acute monocytic leukemia after infection with Clostridium septicum. Int J Lab Hematol 2007;29:386–389.
   PubMed Web of Science ®Google Scholar
• Daccache A, Kizhakekuttu T, Siebert J, et al. Hematologic and cytogenetic spontaneous remission in acute monocytic leukemia (FAB M5b) with trisomy 8. J Clin Oncol 2007;25:344–346.
   PubMed Web of Science ®Google Scholar
• Delmer A, Heron E, Marie JP, et al. Spontaneous remission in acute myeloid leukaemia. Br J Haematol 1994;87:880–882.
   PubMed Web of Science ®Google Scholar
• Hudecek M, Bartsch K, Jakel N, et al. Spontaneous remission of acute myeloid leukemia relapse after hematopoietic cell transplantation in a high-risk patient with 11q23/MLL abnormality. Acta Haematol 2008;119:111–114.
   PubMed Web of Science ®Google Scholar
• Paul R, Remes K, Lakkala T, et al. Spontaneous remission in acute myeloid leukaemia. Br J Haematol 1994;86:210–212.
   PubMed Web of Science ®Google Scholar
• Rajni A, Aenugopal P, Nair CN et al. Spontaneous complete remission in acute non-lymphoblastic leukemia. Indian J Cancer 1988;25:151–156.
   PubMedGoogle Scholar
• Fassas A, Sakellari I, Anagnostopoulos A, et al. Spontaneous remission of acute myeloid leukemia in a patient with concurrent Pneumocystis carinii pneumonia. Nouv Rev Fr Hematol 1991;33:363–364.
   PubMedGoogle Scholar
• Raza A, Gill LM, Rakowski I, Preisler HD. Spontaneous remission in acute nonlymphocytic leukemia. NY State J Med 1985;85:269–270.
   PubMedGoogle Scholar
• Schwarz A, Levine LH. Prolonged spontaneous remission in acute leukemia. NY State J Med 1951;51:2413–2415.
   PubMedGoogle Scholar
• Narayanan MN, Lewis MJ. Spontaneous complete remission of acute myeloid leukaemia with interstitial deletion of chromosome 5. Clin Lab Haematol 1991;13:391–395.
   PubMedGoogle Scholar
• Maywald O, Buchheidt D, Bergmann J, et al. Spontaneous remission in adult acute myeloid leukemia in association with systemic bacterial infection-case report and review of the literature. Ann Hematol 2004;83:189–194.
   PubMed Web of Science ®Google Scholar
• Antunez de Mayolo J, Ahn YS, Temple JD, et al. Spontaneous remission of acute leukemia after the termination of pregnancy. Cancer 1989;63:1621–1623.
   PubMed Web of Science ®Google Scholar
• Marisavljevic D, Markovic O, Zivkovic R. An unusual case of smoldering AML with prolonged indolent clinical course and spontaneous remission in the terminal phase. Med Oncol 2009;26: 476–479.
   PubMed Web of Science ®Google Scholar
• Kizaki M, Ogawa T, Watanabe Y, et al. Spontaneous remission in hypoplastic acute leukemia. Keio J Med 1988;37:299–307.
   PubMedGoogle Scholar
• Fozza C, Bellizzi S, Bonfigli S, et al. Cytogenetic and hematological spontaneous remission in a case of acute myelogenous leukemia. Eur J Haematol 2004;73:219–222.
   PubMed Web of Science ®Google Scholar
• Adam M, Eltayeb A. Spontaneous remission in acute myeloid leukemia: a case report. Gulf J Oncol 2014;1:84–86.
   PubMedGoogle Scholar